Parallel Advisors’s Pulse Biosciences PLSE Stock Holding History

Parallel Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39K	Buy	+50	New	+$1.18K	﹤0.01%	3613
2025 Q1	–	Sell	-21	Closed	-$366	–	3629
2024 Q4	$366	Buy	+21	New	+$370	﹤0.01%	3285
2021 Q4	–	Sell	-250	Closed	-$5K	–	3244
2021 Q3	$5K	Hold	250	–	–	﹤0.01%	2376
2021 Q2	$4K	Hold	250	–	–	﹤0.01%	2386
2021 Q1	$6K	Hold	250	–	–	﹤0.01%	2139
2020 Q4	$6K	Hold	250	–	–	﹤0.01%	1977
2020 Q3	$3K	Hold	250	–	–	﹤0.01%	2211
2020 Q2	$2K	Hold	250	–	–	﹤0.01%	2220
2020 Q1	$1K	Sell	250 -750	-75%	-$7.78K	﹤0.01%	2316
2019 Q4	$13K	Hold	1,000	–	–	﹤0.01%	1620
2019 Q3	$15K	Hold	1,000	–	–	﹤0.01%	1501
2019 Q2	$13K	Hold	1,000	–	–	﹤0.01%	1475
2019 Q1	$18K	Hold	1,000	–	–	﹤0.01%	1273
2018 Q4	$11K	Hold	1,000	–	–	﹤0.01%	1299
2018 Q3	$14K	Hold	1,000	–	–	﹤0.01%	1307
2018 Q2	$15K	Buy	+1,000	New	+$16.9K	﹤0.01%	1170

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Parallel Advisors's PLSE Position: Q2 2026 in Review

Parallel Advisors opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 50 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #3613 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in PLSE as recently as Q4 2024.

Parallel Advisors first reported a position in PLSE in Q2 2018 and has held it in 16 quarters since. The position peaked at $18K in Q1 2019. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Parallel Advisors held 50 shares of Pulse Biosciences worth $1.39K as of Q2 2026.
Pulse Biosciences was a new Parallel Advisors position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3613 holding.
Parallel Advisors first reported a position in Pulse Biosciences in Q2 2018 and has held it in 16 quarters since.
Parallel Advisors's Pulse Biosciences position peaked at $18K in Q1 2019.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.